Morgan Stanley lowered the firm’s price target on E2open to $4 from $5.10 and keeps an Equal Weight rating on the shares. Retention and bookings continue to improve, but the improvement has been slower than what management anticipated, prompting a FY25 guidance cut and leaving management credibility “now slightly under question,” says the analyst, who thinks management “must execute flawlessly against guidance for shares to re-rate.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ETWO:
- Closing Bell Movers: 10x Genomics falls 27% on’cautious’ customer spending
- E2open cuts FY25 revenue view to $607M-$617M form $630M-$645M
- E2open sees Q3 subscription revenue $130M-$133M
- E2open reports Q2 adjusted EPS 5c, consensus 5c
- Options Volatility and Implied Earnings Moves Today, October 09, 2024